Zegen-X5: Engineered for
Universal Clinical Access.
A chemically synthesized, room-temperature stable small-molecule therapeutic formulated to accelerate physiological tissue repair across chronic, acute, and emergency wounds.
How Zegen-X5 Accelerates Healing
Wound healing follows a coordinated 5-phase biological cascade. In chronic and severe injuries, this cascade stalls at the inflammation phase. Zegen-X5 unlocks tissue regeneration to drive complete, scarless closure.
Bleeding
Hemostasis & Vascular ConstrictionPlatelet aggregation forms the primary fibrin clot to arrest hemorrhaging and release chemotactic growth factors.
Swelling & Inflammation
Debridement & Immune DefenseNeutrophils and M1 macrophages clear necrotic debris and pathogens. In chronic wounds, tissue stalls here.
Tissue Regeneration
Cell Proliferation & AngiogenesisZegen-X5 modulates upstream pathways, reactivating regenerative signaling to multiply keratinocytes and capillary budding.
Wound Contraction
Myofibroblast Centripetal PullMyofibroblasts attach to ECM collagen fibrils, pulling wound margins inward to rapidly reduce wound surface area.
Healed Skin
Collagen Matrix MaturationType III collagen remodels into high-tensile Type I bundles, restoring full barrier function and normal dermal architecture.
Vascular Spasm, Platelet Plug & Primary Hemostasis
Upon mechanical disruption of dermal capillaries, circulating platelets adhere to exposed subendothelial collagen. Degranulation releases PDGF, TGF-β, and fibronectin, establishing the foundational temporary fibrin matrix.
Macrophage Polarization & Pathogen Decontamination
Neutrophils engulf invading bacteria and release proteases. Monocytes differentiate into M1 inflammatory macrophages. In diabetic and chronic ulcers, persistent hyper-inflammation locks the wound in this phase, suppressing regeneration.
Upstream Pathway Modulation & Endogenous Repair Activation
Zegen-X5 selectively modulates upstream master regulatory checkpoints to rescue stalled healing cascades. This reactivates endogenous cellular proliferation, dramatically accelerating keratinocyte expansion, dermal fibroblast migration, and VEGF-mediated capillary neoangiogenesis across the wound bed.
Myofibroblast α-SMA Expression & Edge Approximation
Fibroblasts differentiate into alpha-smooth muscle actin (α-SMA)-positive myofibroblasts. By exerting contractile mechanical forces on surrounding provisional matrix, they bring opposing wound margins into close proximity to minimize open surface area.
Intact Epidermal Barrier & Enhanced Tensile Strength
Final re-epithelialization seals the dermal envelope against environmental pathogens. Collagen bundles reorganize parallel to skin tension lines, restoring ~80% of native uninjured tensile strength while minimizing hypertrophic scar formation.
Where Zegen-X5 Works
By targeting upstream molecular drivers of cellular repair, Zegen-X5 delivers accelerated tissue regeneration across chronic ulcers, acute trauma, veterinary medicine, and austere defense environments.
Diabetic Foot Ulcers (DFU)
Chronic neuropathic and ischemic foot wounds. Overcomes persistent hyper-inflammation and microvascular stalling to accelerate closure and prevent amputations.
Burns & Thermal Trauma
Deep partial-thickness burns, scalding trauma, and radiation-induced skin damage. Restores dermal architecture and reduces hypertrophic scar contracture.
Lacerations & Acute Cuts
Traumatic skin tears, sharp incisions, and high-impact abrasions. Drives rapid centripetal contraction and tensile strength recovery across dermal borders.
Pet Wounds & Veterinary Care
Companion animal care (canine, feline, equine) for surgical incisions, bite lacerations, hot spots, and trauma. Lick-safe, soothing, non-cytotoxic formulation.
Combat Wounds & Defense
Extreme forward-operating field triage for blast lacerations, shrapnel penetration, and battlefield burns. Stable at extreme temperatures without cold-chain storage.
Space Force & Aerospace
Microgravity wound repair and radiation recovery for orbital and deep-space missions. Formulated as a compact, shelf-stable deep-space medical essential.
Single Chemical Entity · Multiple High-Value Indications
By starting with Diabetic Foot Ulcers (ZGX-5) as the regulatory anchor, ZegeneX establishes clean safety and biological proof-of-concept to rapidly expand into burns, post-surgical care, and military emergency medicine.
Tailored Drug Delivery Formats
Engineered for rapid tissue bio-distribution and sustained cellular activation across distinct clinical indications.
Topical Application
Optimized for direct, localized application onto diabetic foot ulcers. Accelerates physiological re-epithelialization while maintaining optimal wound moisture balance.
Protective Matrix Sheet
Tailored for multi-layer compression wrap application in venous leg ulcers. Delivers sustained local therapeutic activity and eliminates painful dressing peel-off trauma.
Touchless Topical Spray
Touchless spray application for acute thermal burns, extensive abrasions, and point-of-injury triage where direct physical wound contact is contraindicated.
Investigational Biological Validation
Competitive Landscape Matrix
Detailed comparison of therapeutic attributes against standard modalities in advanced wound care.
| Feature | Zegen-X5 | Regranex (Becaplermin) | Cellular Tissue (CTPs) | NPWT (Wound Vac) |
|---|---|---|---|---|
| Mechanism | Upstream Cascade Activator | Recombinant rhPDGF-BB | Allogeneic Living Cells | Mechanical Suction |
| Storage Requirements | Ambient (25°C), 9+ Mo (Proven ICH Q1A) | Refrigerated (2°C–8°C) | Cryopreserved (-80°C) | Device Hardware |
| Course Cost | Accessible / High Margin (85%+) | $1,200–$1,800 | $5,000–$15,000 | $3,000–$8,000 |
| Ease of Application | Simple topical application | Daily clinic prep | Surgical graft / sutures | Canister & tubing pump |
| Global Field Deployability | Yes (Any climate or setting) | No (Cold chain dependent) | No (Tertiary hospital only) | Power outlet dependent |